Using electrical stimulation to improve arm function after spinal cord injuries
Upper Extremity Functional Electrical Stimulation (FES) for Restoration of Upper Extremity Function After Spinal Cord Injury (SCI)
This study is testing if a special therapy using electrical stimulation can help people with spinal cord injuries improve their arm function and everyday activities.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 18 Years to 70 Years |
| Sex | All |
| Sponsor | University of Miami Academic / other |
| Locations | 1 site (Miami, Florida) |
| Trial ID | NCT06672458 on ClinicalTrials.gov |
What this trial studies
This research examines the effects of functional electrical stimulation (FES) therapy on arm, brain, and spinal cord function in individuals with spinal cord injuries (SCI) or peripheral nerve injuries (PNI). The study utilizes the MyndMove therapy system to help participants perform everyday tasks, exercise, and strengthen muscles. Participants will be divided into groups based on the timing of their injuries or surgeries, and will receive either short-term or long-term MyndMove therapy. The goal is to better understand recovery patterns and improve rehabilitation outcomes for these patients.
Who should consider this trial
Good fit: Ideal candidates include individuals with traumatic spinal cord injuries at or above the T1 level or those with peripheral nerve injuries, either pre- or post-upper extremity nerve transfer surgery.
Not a fit: Patients with complete spinal cord injuries or those without detectable residual connections in the upper limb may not benefit from this study.
Why it matters
Potential benefit: If successful, this therapy could significantly enhance upper extremity function and quality of life for patients with spinal cord and peripheral nerve injuries.
How similar studies have performed: Other studies utilizing functional electrical stimulation have shown promising results, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria:
1\. Neurological Injury:
1. Traumatic spinal cord injury (SCI): neurological level at or above T1 spinal cord level; AIS A, B, C or D impairment grade
* Group 1 (Acute SCI): Deemed medically stable by medical practitioner, less than 6 months post-injury.
* Group 2 (Chronic SCI): More than 6 months post-injury.
or
2. Peripheral nerve injury (PNI), with or without SCI, who are pre- or post- upper extremity (UE) nerve transfer surgery
* Group 3 (Acute Pre- or Post-UE nerve transfer surgery): Deemed medically stable and safe/appropriate to participate in MyndMove UE FES therapy intervention by referring neurosurgeon within 6 months pre- or post-UE nerve transfer surgery.
* Group 4 (Chronic Post-UE nerve transfer surgery): Deemed medically stable and safe/appropriate to participate in MyndMove UE FES therapy intervention by referring neurosurgeon 6 months or more post-UE nerve transfer surgery.
3\. Has detectable residual connection in upper-limb muscles in at least one of the neurologically affected sides confirmed by a visible contraction when functional electrical stimulation (FES) is applied in at least one upper extremity muscle at baseline.
4\. Has detectable motor function in at least 1 upper extremity muscle on 1 neurologically affected side confirmed by voluntary electromyography (EMG) or detectable motor evoked potential (MEP) at the baseline assessment. 5. (Aim 2 only) Able to commit to intervention and assessment sessions over a maximum duration of 4 months.
Exclusion Criteria
1. Traumatic brain injury, stroke, multiple sclerosis, or other disorders that could affect neuromotor function.
2. Severe spasticity that could prevent the study protocol as determined by the investigator.
3. Major executive dysfunction, dementia, depression, neurocognitive impairments, or other major medical co-morbidities.
4. Has contraindications for transcutaneous stimulation using FES such as breakdown of skin in the area that will come into contact with electrodes, thrombosis, or skin disease
5. Poorly managed autonomic dysreflexia that could be triggered by FES.
6. Unhealed upper extremity fracture, contracture, or pressure sore.
7. Implanted neurostimulator (e.g., deep brain stimulation (DBS), epidural/subdural, vagal nerve stimulation (VNS))
8. Cardiac pacemaker or intracardiac lines.
9. Individuals who require therapy or other care that could interfere with participation in the study.
10. Individuals on investigational drugs or any other intervention known to have a potential impact on neuromotor function.
11. Individuals with substance disorders, including alcoholism and drug abuse.
12. Individuals who are pregnant, breastfeeding, or the desire to become pregnant during the study.
13. In the opinion of the investigators, the study is not safe or appropriate for the participant.
Where this trial is running
Miami, Florida
- University of Miami - Miami Project to Cure Paralysis — Miami, Florida, United States (Recruiting)
Study contacts
- Principal investigator: Matija Milosevic, PhD — University of Miami
- Study coordinator: Cristina Thurston, DPT
- Email: cst58@med.miami.edu
- Phone: (305) 243-9301
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.